Genecare Development Limited sold 467,500 shares of TRANSTHERA-B (02617) stock at an average of HKD 12.5786 per share on August 5, 2026, involving about HKD 5.88 million.
Prior to the disposal, Genecare Development Limited's long position in TRANSTHERA-B was 21.96 million shares, representing 7.02%; following the disposal, the holding changed to 21.49 million shares, with the long position ratio falling to 6.87%.